Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a maintenance or release update to the hosting platform rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:59:03.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:13:00.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Status updated to Terminated with <75% participation and related dates; an Informed Consent Form PDF is now listed under Study Documents (M.D. Anderson Cancer Center).
    Difference
    1%
    Check dated 2026-02-25T18:25:42.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Administrative site updates were made: Revision: v3.4.2 was added and an older notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:15:27.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.